Stock Research Reports

Documents

Order by : Name | Date | Hits [ Ascendant ]

Roth Capital: NEPT Further Steps to Strengthen IP and Commercial Profile for NKO Roth Capital: NEPT Further Steps to Strengthen IP and Commercial Profile for NKO

Date added: 05/23/2012
Filesize: Empty
Downloads: 200
$9 price target after NEPT takes further steps to strengthen IP and
commercial profile for NKO

Maxim Group's Initiation on DNDN Maxim Group's Initiation on DNDN

Date added: 05/22/2012
Filesize: Empty
Downloads: 452
Maxim initiates coverage with a SELL recommendation.

LPTN Investor Presentation LPTN Investor Presentation

Date added: 11/14/2011
Filesize: Empty
Downloads: 472

Standard & Poor's MarketScope on NWBO Standard & Poor's MarketScope on NWBO

Date added: 10/25/2011
Filesize: Empty
Downloads: 290

Peer Reviewed Study: Stromal Vascular Fraction Stem Cells Peer Reviewed Study: Stromal Vascular Fraction Stem Cells

hot!
Date added: 10/18/2011
Filesize: Empty
Downloads: 544
Intellicell - SVFC 1st published research paper

Sanuwave - Goldman Research Sanuwave - Goldman Research

Date added: 09/28/2011
Filesize: Empty
Downloads: 360

Roth Capital on Neptune (Nasdaq:NEPT) Roth Capital on Neptune (Nasdaq:NEPT)

hot!
Date added: 09/16/2011
Filesize: Empty
Downloads: 598

Oncosec Investor Presentation Oncosec Investor Presentation

hot!
Date added: 05/12/2011
Filesize: Empty
Downloads: 827

Needham initiation report on ASTM (4/4/2011) Needham initiation report on ASTM (4/4/2011)

hot!
Date added: 04/18/2011
Filesize: Empty
Downloads: 2401

Needham & Co. on Pluristem ($5 PT) Needham & Co. on Pluristem ($5 PT)

Date added: 04/07/2011
Filesize: Empty
Downloads: 477
<< Start < Prev 1 3 4 > End >>
Page 1 of 4
BioMedReports Galectin Announces First Patient Dosed in Phase 1 Trial of GR-MD-02; Targeted Medical Pharma Completes Middle ... http://t.co/ia50TaWnPa
BioMedReports Key milestone for brown fat research with a ground-breaking MRI scan http://t.co/MQTeFGrMOj
BioMedReports Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11; Cleveland Biolabs Successfuly Close of... http://t.co/vhI1HwOLoB
navigation
Benzinga.com supporter Seeking Alpha Certified